Weight loss achieved through semaglutide use may indirectly benefit certain digestive conditions associated with obesity, such as gastroesophageal reflux disease (GERD) or metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD), but this represents a secondary effect rather than direct gut healing
, Tate, C
A multidisciplinary collaboration between information technology, physicians, nursing, infection prevention, and educators contributed to the successful rollout at IMH, even though the implementation and education were modified
For patients using these therapiesor considering themdifferences in composition could matter, particularly when drugs are intended for chronic use
Additional safety considerations include risk of dehydration and acute kidney injury, potential worsening of diabetic retinopathy with rapid glucose improvement (particularly with semaglutide), and hypoglycemia risk when combined with insulin or sulfonylureas
This lack of oversight leads to uncertainties around dosage, effectiveness, and potential side effects when supplements are taken alongside prescription medications